CAS: 1644545-52-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Vorasidenib REF: IN-DA01EOEICAS: 1644545-52-7 | 98% | To inquire | Mon 16 Dec 24 |
 | Vorasidenib REF: TM-T7307CAS: 1644545-52-7 | 99.57% | 52.00 €~762.00 € | Mon 23 Dec 24 |
 | Vorasidenib (AG-881) REF: 3D-UQC54552CAS: 1644545-52-7 | Min. 95% | To inquire | Mon 27 Jan 25 |
Vorasidenib
CAS:1644545-52-7
Formula:
C14H13ClF6N6
Purity:
98%
Color and Shape:
Solid
Molecular weight:
414.7366
Ref: IN-DA01EOEI
| 1g | To inquire | ||
| 1mg | 38.00 € | ||
| 5mg | 66.00 € | ||
| 10mg | 96.00 € | ||
| 25mg | 167.00 € | ||
| 50mg | 158.00 € | ||
| 100mg | 267.00 € | ||
| 250mg | 600.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Vorasidenib
CAS:1644545-52-7
Vorasidenib (PVM/MA) is an inhibitor of mutant isocitrate dehydrogenase (IDH; IC50s = 31.9 and 31.7 …
Formula:
C14H13ClF6N6
Purity:
99.57%
Color and Shape:
Solid
Molecular weight:
414.74
Ref: TM-T7307
| 1mg | 52.00 € | ||
| 2mg | 78.00 € | ||
| 5mg | 118.00 € | ||
| 10mg | 185.00 € | ||
| 25mg | 353.00 € | ||
| 50mg | 527.00 € | ||
| 100mg | 762.00 € | ||
| 1mL*10mM (DMSO) | 107.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
Vorasidenib (AG-881)
CAS:1644545-52-7
Vorasidenib is a drug that has been approved for the treatment of adults with newly …
Formula:
C14H13ClF6N6
Purity:
Min. 95%
Molecular weight:
414.74 g/mol
Ref: 3D-UQC54552
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 27 Jan 2025
